{"id":33322,"date":"2020-08-12T16:35:07","date_gmt":"2020-08-12T15:35:07","guid":{"rendered":"https:\/\/www.biotechpharmasummit.com\/?page_id=33322"},"modified":"2023-05-01T22:23:35","modified_gmt":"2023-05-01T21:23:35","slug":"stefan-kostense","status":"publish","type":"page","link":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/stefan-kostense\/","title":{"rendered":"Stefan Kostense"},"content":{"rendered":"
\n\n\t

Stefan Kostense, PhD<\/h2>\n

Director, Biomarkers, Janssen (Johnson & Johnson).<\/h4>\n\t

After obtaining his PhD on HIV specific immunity, he joined Crucell\/Janssen as a scientist, evaluating vaccine immunogenicity in preclinical models. He has set up up the Clinical Immunology department of 35 FTE, and set up a GLP and GCLP compliant laboratory including LIMS, for the analysis of toxicity and clinical samples, supporting the development of antibody therapeutics and vaccines. As department head he was responsible for the scientific strategy, operational efficiency, and effective outsourcing to CRO’s or collaboration with external key opinion leaders.<\/p>\n

After 20 years in infectious diseases, he moved to the field of biomarkers for non infectious diseases, aiming to predict disease and to prevent and intercept disease.<\/p>\n\t\t\t\t\t\t\t\"Stefan_Kostense_Janssen_BioTech_Pharma_Summit_profile_2\"\t\t\t\t\t\t\t\n

\n\tTitle: Biomarkers predicting the development of Alzheimer’s Disease\n\t<\/h3>\n\t\n\t\t\t\t\tPresentation available only at SocioPharma.com\n\t<\/a>\n

\n\t\t\t\n\tOn the Web\n\t\t\t<\/a>\n\t<\/h4>\n\t

https:\/\/www.janssen.com\/<\/a><\/p>\n

\n\t\t\t\n\tOn LinkedIn\n\t\t\t<\/a>\n\t<\/h4>\n\t

Visit Profile<\/a><\/p>\n\n<\/div>","protected":false},"excerpt":{"rendered":"

Stefan Kostense, PhD Director, Biomarkers, Janssen (Johnson & Johnson). After obtaining his PhD on HIV specific immunity, he joined Crucell\/Janssen as a scientist, evaluating vaccine immunogenicity in preclinical models. He has set up up the Clinical Immunology department of 35 FTE, and set up a GLP and GCLP compliant laboratory including LIMS, for the analysis…<\/p>\n","protected":false},"author":1,"featured_media":33323,"parent":33267,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-33322","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"\nStefan Kostense • BioTech Pharma Summit<\/title>\n<meta name=\"description\" content=\"After obtaining his PhD on HIV specific immunity, he joined Crucell\/Janssen as a scientist, evaluating vaccine immunogenicity in preclinical models.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/stefan-kostense\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Stefan Kostense • BioTech Pharma Summit\" \/>\n<meta property=\"og:description\" content=\"After obtaining his PhD on HIV specific immunity, he joined Crucell\/Janssen as a scientist, evaluating vaccine immunogenicity in preclinical models.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/stefan-kostense\/\" \/>\n<meta property=\"og:site_name\" content=\"BioTech Pharma Summit\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/biotechpharmasummit\/\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-01T21:23:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Stefan_Kostense_Janssen_BioTech_Pharma_Summit_profile.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@biotechsummit\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/stefan-kostense\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/stefan-kostense\/\",\"name\":\"Stefan Kostense • BioTech Pharma Summit\",\"isPartOf\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/stefan-kostense\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/stefan-kostense\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Stefan_Kostense_Janssen_BioTech_Pharma_Summit_profile.jpg\",\"datePublished\":\"2020-08-12T15:35:07+00:00\",\"dateModified\":\"2023-05-01T21:23:35+00:00\",\"description\":\"After obtaining his PhD on HIV specific immunity, he joined Crucell\/Janssen as a scientist, evaluating vaccine immunogenicity in preclinical models.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/stefan-kostense\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/stefan-kostense\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/stefan-kostense\/#primaryimage\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Stefan_Kostense_Janssen_BioTech_Pharma_Summit_profile.jpg\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Stefan_Kostense_Janssen_BioTech_Pharma_Summit_profile.jpg\",\"width\":900,\"height\":900},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/stefan-kostense\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Companion Diagnostics & Biomarkers 2019 Speakers\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Stefan Kostense\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"name\":\"BioTech Pharma Summit\",\"description\":\"The Tomorrow's healthcare congress\",\"publisher\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\",\"name\":\"EPM Group\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"width\":2000,\"height\":2000,\"caption\":\"EPM Group\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/biotechpharmasummit\/\",\"https:\/\/x.com\/biotechsummit\",\"https:\/\/www.instagram.com\/biotechpharmasummit\/\",\"https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Stefan Kostense • BioTech Pharma Summit","description":"After obtaining his PhD on HIV specific immunity, he joined Crucell\/Janssen as a scientist, evaluating vaccine immunogenicity in preclinical models.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/stefan-kostense\/","og_locale":"en_US","og_type":"article","og_title":"Stefan Kostense • BioTech Pharma Summit","og_description":"After obtaining his PhD on HIV specific immunity, he joined Crucell\/Janssen as a scientist, evaluating vaccine immunogenicity in preclinical models.","og_url":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/stefan-kostense\/","og_site_name":"BioTech Pharma Summit","article_publisher":"https:\/\/www.facebook.com\/biotechpharmasummit\/","article_modified_time":"2023-05-01T21:23:35+00:00","og_image":[{"width":900,"height":900,"url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Stefan_Kostense_Janssen_BioTech_Pharma_Summit_profile.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@biotechsummit","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/stefan-kostense\/","url":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/stefan-kostense\/","name":"Stefan Kostense • BioTech Pharma Summit","isPartOf":{"@id":"https:\/\/www.biotechpharmasummit.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/stefan-kostense\/#primaryimage"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/stefan-kostense\/#primaryimage"},"thumbnailUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Stefan_Kostense_Janssen_BioTech_Pharma_Summit_profile.jpg","datePublished":"2020-08-12T15:35:07+00:00","dateModified":"2023-05-01T21:23:35+00:00","description":"After obtaining his PhD on HIV specific immunity, he joined Crucell\/Janssen as a scientist, evaluating vaccine immunogenicity in preclinical models.","breadcrumb":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/stefan-kostense\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/stefan-kostense\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/stefan-kostense\/#primaryimage","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Stefan_Kostense_Janssen_BioTech_Pharma_Summit_profile.jpg","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Stefan_Kostense_Janssen_BioTech_Pharma_Summit_profile.jpg","width":900,"height":900},{"@type":"BreadcrumbList","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/stefan-kostense\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.biotechpharmasummit.com\/"},{"@type":"ListItem","position":2,"name":"Companion Diagnostics & Biomarkers 2019 Speakers","item":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/"},{"@type":"ListItem","position":3,"name":"Stefan Kostense"}]},{"@type":"WebSite","@id":"https:\/\/www.biotechpharmasummit.com\/#website","url":"https:\/\/www.biotechpharmasummit.com\/","name":"BioTech Pharma Summit","description":"The Tomorrow's healthcare congress","publisher":{"@id":"https:\/\/www.biotechpharmasummit.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.biotechpharmasummit.com\/#organization","name":"EPM Group","url":"https:\/\/www.biotechpharmasummit.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","width":2000,"height":2000,"caption":"EPM Group"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/biotechpharmasummit\/","https:\/\/x.com\/biotechsummit","https:\/\/www.instagram.com\/biotechpharmasummit\/","https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/33322","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/comments?post=33322"}],"version-history":[{"count":6,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/33322\/revisions"}],"predecessor-version":[{"id":38290,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/33322\/revisions\/38290"}],"up":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/33267"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media\/33323"}],"wp:attachment":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media?parent=33322"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}